methyl 4-chloropyridine-2-carboxylate,hydrochloride

We are methyl 4-chloropyridine-2-carboxylate,hydrochloride CAS:176977-85-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: methyl 4-chloropyridine-2-carboxylate,hydrochloride
CAS.NO:  176977-85-8
Synonyms:
Methyl 4-chloropyridine-2-carboxylate hydrochloride
Methyl 4-chloropicolinate hydrochloride
Methyl 4-chloro-2-pyridinecarboxylate hydrochloride
4-Chloro-pyridine-2-carboxylic acid methyl ester hydrochloride

Molecular Formula: C7H7Cl2NO2
Molecular Weight:  208.04200

Physical and Chemical Properties:
Density:1.294g/cm3
Boiling point:264ºC at 760 mmHg
Melting point:136-138ºC
Flash point: 113.5ºC
Refractive index:1.506

Specification:
Appearance: Light Yellow Solid
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sorafenib tosylate  CAS:475207-59-1
Intermediates of Sorafenib CAS:284461-73-0

Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.1-isocyanato-4-propan-2-yl benzene CAS:31027-31-3 In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.Ethyl 2-bromopropionate In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.Clorhidrato de 5,6-dietil-2,3-dihidro-1H-inden-2-amina CAS:312753-53-0 In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.